Viewing StudyNCT00516191



Ignite Creation Date: 2024-05-05 @ 6:36 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00516191
Status: WITHDRAWN
Last Update Posted: 2015-03-04
First Post: 2007-08-13

Brief Title: A Phase III Study of Liposomal Doxorubicin DoxilMelphalanBortezomib Velcade in RelapsedRefractory Multiple Myeloma
Sponsor: University of California San Francisco
Organization: University of California San Francisco

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-10
Start Date Type: None
Primary Completion Date: 2010-10
Primary Completion Date Type: ACTUAL
Completion Date: 2010-12
Completion Date Type: ACTUAL
First Submit Date: 2007-08-13
First Submit QC Date: August 13 2007
Study First Post Date: 2007-08-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-03-03
Last Update Post Date: 2015-03-04
Last Update Post Date Type: ESTIMATED